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This carefully performed analysis of the National Inpatient Sample database highlights both the strengths and weaknesses of "big data" in our quest for improving patient outcomes from the complications of vascular disease.
Despite significantly greater comorbidities, the thoracic endovascular aortic repair (TEVAR) group had better hospital outcomes than the group undergoing open repair, in all venues. The substantial increase in TEVAR over nonoperative management reflects the physician's and patient's perception that "minimally invasive" techniques deserve application in populations that were previously believed unfit for open repair, and the decreased inhospital mortality would appear to support this position. What is reassuring is that improved early outcomes support that TEVAR is a welcome addition to the management of a complex and often fatal problem.
What the study does not addressdand by the nature of the database is incapable of doingdis the long-term outcome for the patients offered treatment, particularly for the very elderly, who have experienced the greatest increase in intervention. With acute renal failure and respiratory failure occurring in 22% and 33%, respectively, and discharge to home of only 27%, the long-term impact on quality of life may not reflect the same optimism associated with a decreasing hospital mortality. Whereas the introduction of less invasive therapies has clearly broadened the eligibility for patients at high risk or unfit for traditional open repair, we must be cautious to ensure that short-term markers of success, particularly in-hospital mortality, are balanced against patientcentered expectations.
Hospital readmissions, a useful surrogate for a successful result, cannot be linked with the National Inpatient Sample database. It is possible that using linked hospital data will improve our understanding of the long-term outcomes of our interventions. 3 as independent predictors of poor outcomes, with impact beyond the traditional risks of heart failure, cerebrovascular diseases, and renal failure. The accuracy of several ruptured aneurysm scoring systems to predict futility has been challenged, 4 and this relates only to mortality. It remains the responsibility of the surgeon to help patients understand how their individual situation relates to predictive algorithms. 5 We owe it to our patients to place our ability to perform a procedure in the context of our patient's goals, it is to be hoped with sound predictive data to support these decisions.
